Knight Therapeutics Inc GUD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 5.79
- Day Range
- CAD 5.73–5.80
- 52-Week Range
- CAD 4.35–5.95
- Bid/Ask
- CAD 5.72 / CAD 5.74
- Market Cap
- CAD 580.72 Mil
- Volume/Avg
- 3,747 / 73,302
Key Statistics
- Price/Earnings (Normalized)
- 201.55
- Price/Sales
- 1.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 9.13%
Company Profile
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets . The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically the company generates revenue from Brazil, Colombia, Argentina, Rest of LATAM, Canada, and Other, with the majority revenue generated from the Brazil region.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 725
- Website
- https://www.gud-knight.com
Comparables
Valuation
|
Metric
|
GUD
|
543322
|
1SKF401E
|
|---|---|---|---|
Price/Earnings (Normalized) | 201.55 | 21.25 | — |
Price/Book Value | 0.78 | 4.29 | — |
Price/Sales | 1.90 | 4.38 | — |
Price/Cash Flow | 11.51 | 18.33 | — |
Price/Earnings
GUD
543322
1SKF401E
Financial Strength
|
Metric
|
GUD
|
543322
|
1SKF401E
|
|---|---|---|---|
Quick Ratio | 2.35 | 2.64 | 5.90 |
Current Ratio | 3.20 | 4.37 | 5.90 |
Interest Coverage | −1.77 | 409.34 | — |
Quick Ratio
GUD
543322
1SKF401E
Profitability
|
Metric
|
GUD
|
543322
|
1SKF401E
|
|---|---|---|---|
Return on Assets (Normalized) | 1.07% | 16.82% | 11.93% |
Return on Equity (Normalized) | 1.35% | 20.87% | 14.50% |
Return on Invested Capital (Normalized) | 1.22% | 20.73% | 14.48% |
Return on Assets
GUD
543322
1SKF401E
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Jsrymygg | Fzvwn | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Cnrybhkxf | Mfjqryd | $69.8 Bil | |
HLN
| Haleon PLC ADR | Dtywhfqtx | Przd | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xlvnbmpz | Slj | $14.6 Bil | |
VTRS
| Viatris Inc | Xstbhws | Qvgr | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Gfpcbyvgm | Kfp | $12.6 Bil | |
CTLT
| Catalent Inc | Vpffcczyf | Cjnzbfk | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Qhlkjlcfd | Bll | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Srstrxd | Czd | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qgzlknh | Tjjsx | $3.6 Bil |